342 top medical experts on Immunoblastic Lymphadenopathy across 32 countries and 21 U.S. states, including 196 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphoproliferative Disorders (2,703), Lymphadenopathy (3,986).
  4. Clinical Trials ClinicalTrials.gov : at least 117 including 11 Active, 62 Completed, 14 Recruiting
  5. Synonyms: Angioimmunoblastic Lymphadenopathy


  

        

                    


    Computing Expert Listing ...

);